SCHEMBL25870352

SCHEMBL25870352

COC(=O)[C@@H]1[C@@H](c2ccc(F)c(C)c2)C1(Cl)Cl

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC9A1 P19634 2/20 0.51
HTT P42858 3/20 0.41
LMNA P02545 3/20 0.41
HPGD P15428 1/20 0.41
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
ALDH1A1 P00352 1/20 0.40
RECQL P46063 1/20 0.40
MAPT P10636 1/20 0.40
SLC6A2 P23975 2/20 0.38
SLC6A4 P31645 2/20 0.38
SLC6A3 Q01959 2/20 0.38
CHRNA1 P02708 1/20 0.38
CHRNG P07510 1/20 0.38
ITGA5 P08648 1/20 0.38
CHRNB1 P11230 1/20 0.38
CHRNB2 P17787 1/20 0.38
CHRNB4 P30926 1/20 0.38
CHRNA3 P32297 1/20 0.38
CHRNA4 P43681 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23961598 0.86 MEN1 (0.40) SLC9A1HTTLMNAMEN1KMT2A
SCHEMBL23961555 0.86 MEN1 (0.40) SLC9A1HTTLMNAMEN1KMT2A
SCHEMBL23933303 0.86 MEN1 (0.40) SLC9A1HTTLMNAMEN1KMT2A
SCHEMBL20045114 0.84 SLC9A1 (0.54) SLC9A1HTTLMNAHPGDMEN1
SCHEMBL20045619 0.84 SLC9A1 (0.54) SLC9A1HTTLMNAHPGDMEN1
SCHEMBL18157863 0.84 SLC9A1 (0.54) SLC9A1HTTLMNAHPGDMEN1
SCHEMBL23961569 0.83 MEN1 (0.38) SLC9A1LMNAMEN1KMT2AALDH1A1
SCHEMBL30138574 0.83 MEN1 (0.38) SLC9A1LMNAMEN1KMT2AALDH1A1
SCHEMBL23933318 0.83 MEN1 (0.38) SLC9A1LMNAMEN1KMT2AALDH1A1
SCHEMBL20076441 0.78 SLC9A1 (0.48) SLC9A1HTTLMNAHPGDMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230220427-A1 PROCESSES RELATED TO FORMATION OF ARYLCYCLOPROPYL CARBOXYLIC ACIDS CORTEVA AGRISCIENCE LLC (US) 2023-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230220427-A1 PROCESSES RELATED TO FORMATION OF ARYLCYCLOPROPYL CARBOXYLIC ACIDS DDT, PCCA, DDC SLC9A1 4409/4885HTT 2565/4885LMNA 3438/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.